Second prostate-specific membrane antigen PET scan can change treatment for nearly half of prostate cancer patients

A 2nd prostate-specific membrane antigen (PSMA) PET scan changed attraction plans for astir fractional of patients whose archetypal scan was negative, according to caller probe published successful the July contented of The Journal of Nuclear Medicine. Findings from the repetition PSMA scans, which included some section and distant disease, resulted successful a alteration successful absorption for astir 50% of these patients.